Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
Aslan Pharmaceuticals Ltd
Cash from Operating Activities
Aslan Pharmaceuticals Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
|
Cash from Operating Activities
-$20.4m
|
CAGR 3-Years
12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Aslan Pharmaceuticals Ltd's Cash from Operating Activities?
Cash from Operating Activities
-20.4m
USD
Based on the financial report for Sep 30, 2023, Aslan Pharmaceuticals Ltd's Cash from Operating Activities amounts to -20.4m USD.
What is Aslan Pharmaceuticals Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
12%
Over the last year, the Cash from Operating Activities growth was 4%. The average annual Cash from Operating Activities growth rates for Aslan Pharmaceuticals Ltd have been 12% over the past three years .